Big Picture – A Deep Dive Examination of Heritage Cannabis
Heritage Cannabis Snapshot
We aim to become an industry-leading and vertically integrated cannabis provider, working to stay at the forefront of innovative technology and supply chain developments to serve partners, retailers and consumers across Canada with pride.
From coast-to-coast, we employ state-of-the-art technology and techniques to cultivate and process cannabis and to embed it into healthcare practices.
Four operating subsidiaries form Heritage Cannabis, creating a diverse offering to advance our vision and cement our place in the market.
Voyage Cannabis Corp, previously known as PhyeinMed Inc. holds a Health Canada issued cultivation, processing and medical sales licence. Located in Falkland, British Columbia, Voyage holds high quality standards in the industry when it comes to cultivation, extraction, patient services and sale of cannabis products. With a strong emphasis on cannabis oils, Voyage’s offerings will include a full and unique line of cannabis products for both for medical and recreational markets
CannaCure, based in Fort Erie, Ontario, is a Health Canada license holder under the Cannabis Act. It’s 122,000 square foot, former GMP facility is suitable for substantial processing, manufacturing and distribution of cannabis products. CannaCure will be entering various partnerships to prepare for the expected growth in the Company’s extraction business and to meet the demands of the consumables market when approved by Health Canada.
Purefarma is an extraction service company which specializes in the development of medicinal grade cannabis formulations for pharmaceutical, recreational and cosmeceutical markets. Purefarma has also developed its own propriety modifications to industry standard machinery and has industrialized a variety of proprietary production processes with inhouse design-built equipment. Purefarma is sought after sought after to perform extraction by licensed producers, many of which do not have the extraction capability to meet market demands or their contractual commitments.
BriteLife is driven by a team of physicians and allied healthcare professionals aimed to identify and correlate individual genotypes through a proprietary DNA Variant Report targeted to assist patients with individualized custom solutions. In addition BritLife is establishing a patient education platform to include health and wellness support, medical resources, and access to experts.
Adam Roy, Investor Relations
929 Mainland Street
77 Bloor Street